Transgene Biotek Limited (TRABI.BO)

INR 7.34

(-0.53%)

Total Liabilities Summary of Transgene Biotek Limited

Transgene Biotek Limited's latest annual total liabilities in 2023 was 393.11 Million INR , down -69.99% from previous year.
Transgene Biotek Limited's latest quarterly total liabilities in 2023 FY was 393.11 Million INR , down -69.99% from previous quarter.
Transgene Biotek Limited reported annual total liabilities of 1.3 Billion INR in 2022, up 0.98% from previous year.
Transgene Biotek Limited reported annual total liabilities of 1.29 Billion INR in 2021, down -3.65% from previous year.
Transgene Biotek Limited reported quarterly total liabilities of 1.31 Billion INR for 2023 Q2, down 0.0% from previous quarter.
Transgene Biotek Limited reported quarterly total liabilities of 393.11 Million INR for 2023 Q4, down 0.0% from previous quarter.

Annual Total Liabilities Chart of Transgene Biotek Limited (2023 - 2006)

Historical Annual Total Liabilities of Transgene Biotek Limited (2023 - 2006)

Year	Total Liabilities	Total Liabilities Growth
2023	393.11 Million INR	-69.99%
2022	1.3 Billion INR	0.98%
2021	1.29 Billion INR	-3.65%
2020	1.34 Billion INR	0.42%
2019	1.34 Billion INR	0.88%
2018	1.32 Billion INR	-0.9%
2017	1.34 Billion INR	-3.65%
2016	1.39 Billion INR	0.48%
2015	1.38 Billion INR	-9.08%
2014	1.52 Billion INR	0.01%
2013	1.52 Billion INR	226.39%
2012	466.84 Million INR	-14.84%
2011	548.22 Million INR	108.85%
2010	262.49 Million INR	59.79%
2009	164.27 Million INR	9.63%
2008	149.85 Million INR	-21.71%
2007	191.4 Million INR	35.91%
2006	140.83 Million INR	0.0%

Year	Total Liabilities	Total Liabilities Growth
2023 FY	393.11 Million INR	-69.99%
2023 Q2	1.31 Billion INR	0.0%
2023 Q4	393.11 Million INR	0.0%
2023 Q3	- INR	-100.0%
2023 Q1	- INR	-100.0%
2022 Q4	1.3 Billion INR	0.0%
2022 FY	1.3 Billion INR	0.98%
2022 Q1	- INR	-100.0%
2022 Q2	381.06 Million INR	0.0%
2022 Q3	- INR	-100.0%
2021 Q4	1.29 Billion INR	0.0%
2021 Q2	1.34 Billion INR	0.0%
2021 FY	1.29 Billion INR	-3.65%
2021 Q1	- INR	-100.0%
2021 Q3	- INR	-100.0%
2020 FY	1.34 Billion INR	0.42%
2020 Q1	- INR	-100.0%
2020 Q3	- INR	-100.0%
2020 Q2	1.34 Billion INR	0.0%
2020 Q4	1.34 Billion INR	0.0%
2019 Q3	- INR	-100.0%
2019 FY	1.34 Billion INR	0.88%
2019 Q2	1.33 Billion INR	0.0%
2019 Q4	1.34 Billion INR	0.0%
2018 FY	1.32 Billion INR	-0.9%
2018 Q1	- INR	0.0%
2018 Q4	1.32 Billion INR	0.0%
2017 FY	1.34 Billion INR	-3.65%
2016 FY	1.39 Billion INR	0.48%
2015 FY	1.38 Billion INR	-9.08%
2014 FY	1.52 Billion INR	0.01%
2013 FY	1.52 Billion INR	226.39%
2012 FY	466.84 Million INR	-14.84%
2012 Q1	608.6 Million INR	0.0%
2012 Q2	1.35 Billion INR	121.95%
2012 Q4	466.84 Million INR	-68.81%
2012 Q3	1.49 Billion INR	10.8%
2011 FY	548.22 Million INR	108.85%
2010 FY	262.49 Million INR	59.79%
2009 FY	164.27 Million INR	9.63%
2008 FY	149.85 Million INR	-21.71%
2007 FY	191.4 Million INR	35.91%
2006 FY	140.83 Million INR	0.0%

Peer Total Liabilities Comparison of Transgene Biotek Limited

Name	Total Liabilities	Total Liabilities Difference
Alfavision Overseas (India) Limited	1.36 Billion INR	71.22%
Biocon Limited	307.95 Billion INR	99.872%
Blue Jet Healthcare Limited	2.13 Billion INR	81.598%
Concord Biotech Limited	1.74 Billion INR	77.416%
Dishman Carbogen Amcis Limited	39.53 Billion INR	99.006%
FERMENTA BIOTECH LIMITED	2.62 Billion INR	85.034%
GENOMIC VALLEY BIOTECH LIMITED	7.91 Million INR	-4865.954%
Lyka Labs Limited	884.58 Million INR	55.56%
Panacea Biotec Limited	4.02 Billion INR	90.222%
SAMSRITA LABS LIMITED	32.93 Million INR	-1093.596%
Servoteach Industries Limited	5275.00 INR	-7452241.232%
SMS Lifesciences India Limited	1.96 Billion INR	80.033%
Supriya Lifescience Limited	1.05 Billion INR	62.869%
Syngene International Limited	18.93 Billion INR	97.924%
TAKE Solutions Limited	969.78 Million INR	59.464%
Titan Biotech Limited	231.28 Million INR	-69.967%
Vanta Bioscience Limited	724.23 Million INR	45.721%